CSPC Pharmaceutical Group Limited (HKG:1093)
Hong Kong
· Delayed Price · Currency is HKD 8.36
-0.05 (-0.59%)
Apr 29, 2026, 4:08 PM HKT
CSPC Pharmaceutical Group Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | - | 4,328 | 5,873 | 6,091 | 5,605 | Upgrade
|
| Depreciation & Amortization | - | 1,249 | 1,083 | 1,004 | 862.38 | Upgrade
|
| Other Amortization | - | 90.65 | 34.94 | 43.45 | 3.1 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | 23.4 | 22.23 | 7.36 | 10.79 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | 0.18 | 42.32 | 72.11 | 50 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | 151.94 | 177.85 | -148.97 | -242.41 | Upgrade
|
| Loss (Gain) on Equity Investments | - | 89.47 | 54.2 | 15.4 | -22.44 | Upgrade
|
| Stock-Based Compensation | - | 210.45 | 235.09 | 160.73 | 17.73 | Upgrade
|
| Provision & Write-off of Bad Debts | - | 16.3 | 18.41 | -25.73 | 4.07 | Upgrade
|
| Other Operating Activities | - | -807.3 | -330.26 | -391.27 | -263.85 | Upgrade
|
| Change in Accounts Receivable | - | 692.25 | -1,973 | -566.55 | -943.55 | Upgrade
|
| Change in Inventory | - | 8.65 | -583.75 | -42.75 | -617.07 | Upgrade
|
| Change in Accounts Payable | - | -758.87 | 918.13 | 18.45 | 276.79 | Upgrade
|
| Change in Unearned Revenue | - | 135.12 | -275.07 | 468.63 | -44.22 | Upgrade
|
| Change in Other Net Operating Assets | - | -894.41 | -1,118 | 920.34 | -59.87 | Upgrade
|
| Operating Cash Flow | - | 4,535 | 4,179 | 7,627 | 4,637 | Upgrade
|
| Operating Cash Flow Growth | - | 8.52% | -45.21% | 64.50% | -31.20% | Upgrade
|
| Capital Expenditures | - | -2,015 | -1,624 | -2,220 | -1,410 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 99.92 | 139.99 | 16.83 | 85.69 | Upgrade
|
| Cash Acquisitions | - | - | - | -341.91 | -24.35 | Upgrade
|
| Divestitures | - | - | - | - | 150.91 | Upgrade
|
| Sale (Purchase) of Intangibles | - | -560.08 | -265.43 | -484.54 | -339.15 | Upgrade
|
| Investment in Securities | - | -1,615 | 2,171 | -4,075 | 630.71 | Upgrade
|
| Other Investing Activities | - | 232.62 | 443.5 | 308.74 | 269.01 | Upgrade
|
| Investing Cash Flow | - | -3,858 | 865.86 | -6,796 | -637.33 | Upgrade
|
| Long-Term Debt Issued | - | 28 | - | 485.71 | - | Upgrade
|
| Total Debt Issued | - | 28 | - | 485.71 | - | Upgrade
|
| Long-Term Debt Repaid | - | -152.36 | -166.43 | -620.95 | -222.17 | Upgrade
|
| Total Debt Repaid | - | -152.36 | -166.43 | -620.95 | -222.17 | Upgrade
|
| Net Debt Issued (Repaid) | - | -124.36 | -166.43 | -135.24 | -222.17 | Upgrade
|
| Issuance of Common Stock | - | 106.43 | - | - | - | Upgrade
|
| Repurchase of Common Stock | - | -2,196 | -458.95 | -14.21 | -263.51 | Upgrade
|
| Common Dividends Paid | - | -3,234 | -2,726 | -2,097 | -1,691 | Upgrade
|
| Other Financing Activities | - | 194 | 792.06 | 342.34 | -20.16 | Upgrade
|
| Financing Cash Flow | - | -5,253 | -2,560 | -1,904 | -2,197 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | 3.4 | 4.89 | 14.14 | -2.44 | Upgrade
|
| Net Cash Flow | - | -4,573 | 2,490 | -1,059 | 1,800 | Upgrade
|
| Free Cash Flow | - | 2,519 | 2,555 | 5,407 | 3,226 | Upgrade
|
| Free Cash Flow Growth | - | -1.40% | -52.74% | 67.58% | -40.07% | Upgrade
|
| Free Cash Flow Margin | - | 8.69% | 8.12% | 17.48% | 11.58% | Upgrade
|
| Free Cash Flow Per Share | - | 0.21 | 0.21 | 0.45 | 0.27 | Upgrade
|
| Cash Interest Paid | - | 7.65 | 15.99 | 21.54 | 7.66 | Upgrade
|
| Cash Income Tax Paid | - | 1,693 | 1,309 | 1,335 | 1,141 | Upgrade
|
| Levered Free Cash Flow | - | 2,130 | 1,164 | 3,826 | 1,721 | Upgrade
|
| Unlevered Free Cash Flow | - | 2,158 | 1,180 | 3,841 | 1,726 | Upgrade
|
| Change in Working Capital | - | -817.26 | -3,032 | 798.12 | -1,388 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.